Abstract: The invention relates to a novel polypeptide containing the GAFA-domain and GAFB-domain of a human phosphodiesterase 5 (PDE5) and the catalytic domain of an adenylate cyclase, and to the use of this polypeptide in a method for identifying PDE5-modulators.
Type:
Application
Filed:
May 18, 2005
Publication date:
April 2, 2009
Applicant:
Atlanta Pharma AG
Inventors:
Tobias Kanacher, Juergen Linder, Joachim Schultz
Abstract: The invention describes the use of surfactant comprising phospholipids and pulmonary surfactant proteins for the treatment of surgical adhesions.
Type:
Application
Filed:
August 27, 2004
Publication date:
January 8, 2009
Applicant:
Atlanta Pharma AG
Inventors:
Dietrich Hafner, Ralf Harand, Eva Ammon, Ernst Sturm, Klaus Eistetter, Friedemann Taut, Thomas Muller
Abstract: The invention relates to novel pyrimidine derivatives of Formula (1) which are efficacious inhibitors of protein kinases, in particular of one or more isoforms of the protein kinase B/Akt.
Abstract: Compounds of the formula I in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors.
Abstract: The compounds of a certain formula 1, in which R1, R2, R3 and R9 have the meanings as given in the description, are novel effective PDE4 inhibitors.
Abstract: The invention relates to nitrosated imidazopyridines of a certain formula (I), in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting, anti-inflammatory and antibacterial properties.
Type:
Application
Filed:
April 22, 2003
Publication date:
February 16, 2006
Applicant:
Atlanta Pharma AG
Inventors:
Wilm Buhr, Jorg Senn-Bilfinger, Peter Zimmermann
Abstract: Compounds of formula (1) in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.